Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
benazepril hydrochloride 20 mg
Animalcare Limited
QC09AA07
Film coated tablet
benazepril
Dogs
2011-10-28
Revised: July 2013 AN: 00196/2013 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Benazecare Flavour 20 mg Tablets for Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each tablet contains 20 mg benazepril hydrochloride For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Beige oblong tablet with breakline on both sides. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs: Treatment of congestive heart failure. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal failure. Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis. Do not use during pregnancy or lactation (section 4.7). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals No evidence of renal toxicity of the veterinary medicinal product has been observed in dogs during clinical trials, however, as is routine in cases of chronic kidney disease, it is recommended to Revised: July 2013 AN: 00196/2013 Page 2 of 5 monitor plasma creatinine, urea and erythrocyte counts during therapy. ii Special precautions to be taken by the person administering the veterinary medicinal product to animals Wa Read the complete document